الفهرس 
Introduction and RationaleOnly 14 pages are availabe for public view
 |  | from | 138 |  |  |
| | | from | 138 | | |
Abstract
Fibromyalgia is a condition that results in ache all over the body (additionally called widespread pain), sleep problems, fatigue, and regularly emotional and intellectual distress. Fibromyalgia is associated with a high prevalence of emotional and affective disorders. High harm avoidance together with high self-transcendence, low cooperativeness, and low self-directedness have been found as temperament and character features of fibromyalgia patients. Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most human beings infected with the virus will experience mild to moderate respiratory infection and get better without requiring special treatment. The (COVID-19) fear or anxiety can be brought about both by knowing or having more information and by fear of the unknown related to the virus. In fact, an uncertain and continuous threat can become chronic and burdensome. The effects of COVID-19 fear and anxiety on symptom severity, sleep quality and mood in fibromyalgia patients in Egypt has not yet been studied. So the aim of our study was to evaluate the effects of COVID-19 fear and anxiety on symptom severity, sleep quality and mood in fibromyalgia patients attending Suez canal university hospital, through a cross-sectional study conducted upon 43 participants. Most of our participants were females aged between 20-40 years old, we used 5 questionnaires in our study which are the Revised Fibromyalgia Impact Questionnaire (FIQR), the Pittsburgh Sleep Quality Index (PSQI), the Hospital Anxiety Depression Scale D- subscale (HADS-D), Fear of COVID-19 scale (FCV-19), the Coronavirus Anxiety Scale (CAS). Using these questionnaires, we were able to study whether the COVID-19 fear and anxiety had an effect on symptom severity, sleep quality, and mood of fibromyalgia patients or not and whether this effect is statistically significant or not. We found that most of our patients had no fear or anxiety towards COVID-19 to begin with. This could be attributed to the fact that about 50% of patients were living in rural areas, and around 65% had low socioeconomic status, also about 65% were illiterate or had only high school degree.
Summary and Conclusion
64
On the other hand, Our study revealed that there is no significant correlation between FCV-19 score and that of FIQR, PSQI and HADS-D scores, whereas there is a highly positive significant correlation between FIQR and HADS-D (P>
0.001). Also, we discovered that about 72% of our patients had a significantly affected lifestyle using FIQR, while about 88% of our patients had a significantly affected sleep quality using PSQI, whereas about 77% had depression. Meanwhile, the relationship between Revised Fibromyalgia Impact Questionnaire (FIQR) and Hospital Anxiety Depression Scale D- subscale (HADS-D) is statistically significant with a P value of > 0.001 . Finally, our study concluded that there is insignificant effect of COVID-19 fear on symptom severity, sleep quality and mood in fibromyalgia patients, moreover there is no effect at all of COVID-19 anxiety on symptom severity, sleep quality and mood in fibromyalgia patients, and this could be attributed to the fact that about 50% of patients were living in rural areas, and around 65% had low socioeconomic status, also about 65% were illiterate or had only high school degree.
Recommendations
65
Recommendations Based on the study results, the following is recommended: • Similar studies should be carried out but with a larger sample size and in other countries. • Using case control studies instead of cross-sectional studies. • Performing studies on patients who has a past history of COVID-19 infection. • Providing